8.90
Advanced Biomed Inc stock is traded at $8.90, with a volume of 46.11M.
It is up +76.94% in the last 24 hours and up +74.51% over the past month.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
See More
Previous Close:
$5.03
Open:
$6.71
24h Volume:
46.11M
Relative Volume:
57.52
Market Cap:
$14.70M
Revenue:
-
Net Income/Loss:
$174.50K
P/E Ratio:
55.90
EPS:
0.1592
Net Cash Flow:
$-102.70K
1W Performance:
+74.51%
1M Performance:
+74.51%
6M Performance:
+36.92%
1Y Performance:
-35.21%
Advanced Biomed Inc Stock (ADVB) Company Profile
Name
Advanced Biomed Inc
Sector
Industry
Phone
86-21-20510823
Address
401 RYLAND ST, RENO
Compare ADVB vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ADVB
Advanced Biomed Inc
|
8.90 | 14.70M | 0 | 174.50K | -102.70K | 0.1592 |
|
TMO
Thermo Fisher Scientific Inc
|
526.23 | 195.56B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
201.11 | 142.34B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
563.81 | 44.48B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
262.63 | 37.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
130.26 | 36.79B | 7.23B | 1.41B | 1.09B | 4.979 |
Advanced Biomed Inc Stock (ADVB) Latest News
7/20/2026 Market UpdateWinners: GORO, ADVB, LVLULosers: CREG, QMLS, DARES&P 500: -0.2% - Trefis
Market Movers | Winners: ADVB, LVLU, ONCO | Losers: QMLS, DARE, PLAG - Trefis
Advanced Biomed stock is surging: Here's why it is trending - MSN
Why Is New Era Energy Stock Surging Today? - Benzinga
ICMR transfers three biomedical technologies to advance cancer, infectious disease solutions - The Hans India
Advanced Biomed Stock Is Surging: Here's Why It Is Trending - Benzinga
Nasdaq surges 1%; Domino’s shares gain after Q2 Results - MSN
Advanced Biomed Inc. SEC Filing (Jul 20, 2026) - Stock Titan
Top movers in Monday's after hours session - ChartMill
Trending Stocks Today | Zhengye Biotechnology Shoots up 322.63% - Moomoo
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Dow Falls Over 100 Points; IREN Shares Jump - Benzinga
Why Is Penny Stock Advanced Biomed (ADVB) Up Today? - TipRanks
Advanced Biomed Jumps as Traders Focus on Reduced Dilution Risk and AI Transition - Quiver Quantitative
ADVB Stock Surges As Traders Hunt Biotech Momentum - StocksToTrade
Nasdaq Surges 1%; Domino’s Shares Gain After Q2 results - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Morning Market Movers: BIYA, GVH, ADVB, SDOT See Big Swings - RTTNews
Trending Stocks Today | Advanced Biomed Soars 36.97% Pre-Market - Moomoo
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
Advanced Biomed Inc. Files 8-K Current Report with Nasdaq – Key Details for July 2026 - Minichart
Advanced Biomed Ends Equity Purchase Agreement Facility - TipRanks
Stocks to Wtach: Karyopharm Therapeutics, MKDWELL, Advanced Biomed - Moomoo
Advanced Biomed Shares Surge on Termination of Stock Purchase Agreement - Moomoo
Trending Stocks Today | Advanced Biomed Surges 41.46% Post-Market - Moomoo
Advanced Biomed Delivers Notice To Terminate Purchase Agreement With With Helena Global Investment Opportunities I Ltd On July 14SEC Filing - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Advanced Biomed Terminates $25M Equity Purchase Pact With Helena Global Investment Opportunities I - TradingView
Advanced Biomed (ADVB) to terminate $25M equity purchase deal with Helena investor - Stock Titan
Cytovance Biologics Expands Process Development Services with Perfusion Capabilities - Yahoo Finance
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation - Yahoo Finance
Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High - Moomoo
Number of shareholders of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Improve Cell Recovery, Survival, and Expansion Following Passaging, Cryopreservation, and Organoid Harvesting - Yahoo Finance
Price to book forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
Enterprise value to revenue forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
Price to earnings forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
Enterprise value to EBIT forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
Price to sales forward of Advanced Biomed Inc. – NASDAQ:ADVB - TradingView
Auburn University to introduce biomedical engineering graduate and certificate programs - Morningstar
ADVBAdvanced Biomed Inc Earnings - Finviz
Advanced Biomed Inc. 8-K Filing: Company Details, Emerging Growth Status, and Nasdaq Listing for 2026 - Minichart
Advanced Biomed Stockholders Back Board and Governance Decisions - TipRanks
Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals - Stock Titan
Advanced Biomed Inc. Sells Taiwan Subsidiary for $490,000 in Share Purchase Agreement – Nasdaq: ADVB 8-K Filing - Minichart
Advanced BiomedTo Sell Taiwan Subsidiary For $490,000SEC Filing - TradingView
Advanced Biomed Divests Taiwan R&D Unit, Refocuses on AI - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market SessionAlzamend Neuro (NASDAQ:ALZN), Vivos Ther - Benzinga
Advanced Biomed to Divest Taiwan Subsidiary for $490,000; Closing Expected Within Three Months - TradingView
Advanced Biomed (NASDAQ: ADVB) selling Taiwan R&D subsidiary for $490K - Stock Titan
Advanced Biomed Inc. (ADVB) Surges 4%: Testing Key Resistance at $4.9NAAIM Leverage - dars.gov.et
Advanced Biomed Inc Stock (ADVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):